RANBAXY LABORATORIES, LTD. v. LEAVITT

Civil Action No. 05-1838 (RWR).

459 F.Supp.2d 1 (2006)

RANBAXY LABORATORIES, LTD., et al., Plaintiffs, v. Michael O. LEAVITT, et al., Defendants.

United States District Court, District of Columbia.

May 1, 2006.


Attorney(s) appearing for the Case

Kate Cumming Beardsley, Carmen Mercedes Shepard, Buc & Beardsley, Douglas B. Farquhar, John Robert Fleder, Hyman, Phelps & McNamara, P.C., Washington, DC, Jay B. Shapiro, Samuel O. Patmore, Stearns Weaver Miller Weissler Alhadeff & Sitterson, P:A., Miami, FL, for Plaintiffs.

Drake S. Cutini, Department of Justice Office of Consumer Litigation, Washington, DC, for Defendants.


MEMORANDUM OPINION

ROBERTS, District Judge.

Ranbaxy Laboratories Limited1 ("Ranbaxy") and IVAX Pharmaceuticals, Inc. ("IVAX") each sued the Food and Drug Administration ("FDA") under 5 U.S.C. § 706 claiming that the FDA improperly nullified Ranbaxy and IVAX's rights to a 180-day period of exclusive marketing of a generic drug. Ranbaxy and IVAX moved for summary judgment against the FDA seeking to vacate the FDA's...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases